Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells. [electronic resource]
Producer: 20160101Description: 487-99 p. digitalISSN:- 1573-7217
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Cell Line, Tumor
- Co-Repressor Proteins -- antagonists & inhibitors
- Drug Resistance, Neoplasm -- drug effects
- E2F1 Transcription Factor -- metabolism
- Female
- Gene Knockdown Techniques
- Humans
- Mutation
- Phosphorylation
- Transcription Factors -- antagonists & inhibitors
- Triple Negative Breast Neoplasms -- drug therapy
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.